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Impact of dendritic polymers on nanomaterials
R. Soleymana and M. Adeli*b,c
For many years scientists have employed dendritic polymers (dendrimers and hyperbranched polymers) in
association with other nanomaterials (such as graphene, carbon nanotubes, proteins and peptides, as well
as metallic nanoparticles) to synthesize hybrid nanomaterials with improved biocompatibility, biodegrad-
ability, functionality, physicochemical properties and the capability of carrying other molecules. However,
more recent studies demonstrate that one of the less noticed eﬀects and newly observed facets of den-
dritic polymers is their role in changing the structure (shape, size and sheet multiplicity) of the obtained
hybrid nanomaterials, upon covalent and noncovalent interactions. In this review, we intend to have a
more specialized look at these reports and discuss the ‘whys’ and ‘hows’ of this phenomenon.
1. Introduction
Common polymer science is mainly based on linear polymers.
However, because the properties of branched macromolecules
are quite diﬀerent from conventional polymers, in the last
three decades dendritic polymers have found a superior place
in polymer technology. Dendritic structures introduce a variety
of benefits compared to other architectural forms of polymers,
including monodispersity, nanoscale size and host–guest
potential and high ability as molecular shuttles, which
make their passage easier through biological barriers such as
vascular endothelial cells. Because of these outstanding
characteristics of dendritic polymers, their applications
in drug and gene delivery,1–11 cancer diagnosis and
therapy,1,12–18 stimuli-responsive nanocarriers,19,20 cata-
lysis,21,22 self-assembly,23,24 nanomedicine development,25–27
and biomedical applications28–30 have been repeatedly
reviewed. Moreover, various methods for the synthesis and
functionalization of diﬀerent types of dendritic polymers have
been studied in several reviews and papers.22,31–36 In addition
Rouhollah Soleyman
Rouhollah Soleyman was born in
1983 in Karaj (Iran). He
obtained all of his academic
degrees (BSc, MSc and PhD) in
Chemistry from Sharif University
of Technology (2002–2012).
Now, he is senior researcher at
the polymer science and technol-
ogy division of the Research
Institute of Petroleum Industry
(RIPI). His research interests
include synthesis and appli-
cation of polymers, nanoparticles
and hybrid nanomaterials.
Mohsen Adeli
Mohsen Adeli received his under-
graduate degree from Lorestan
University (Iran) in 1996. He
obtained his MS and PhD
degrees from Tabriz University.
After joining Lorestan University
in 2005, he added a postdoctoral
stage from the Institute for
Nanoscience and Nanotechnol-
ogy of Sharif University of
Technology in 2007. He was
promoted to the rank of associate
and full professor in 2010 and
2013, respectively. Mohsen Adeli
was awarded the Razi Prize (2011) and prize for the most develo-
ped professor in chemistry (2012) administered by the Ministry of
Health and Medical Education of Iran and Iran Nanotechnology
Initiative Council, respectively. He joined the Free University of
Berlin as a guest professor in 2014.
aPolymer Science and Technology Division, Research Institute of Petroleum Industry
(RIPI), Tehran, Iran
bDepartment of Chemistry, Faculty of Science, Lorestan University, Khorramabad,
Iran. E-mail: mohadeli@yahoo.com, m.aadeli@fu-berlin.de
cInstitut für Chemie und Biochemie, Freie Universität Berlin, Germany


































View Journal  | View Issue
to these, in a special review, the merits of chemotherapeutic
drugs-dendrimer covalent conjugation have been reported
compared to noncovalent encapsulation methods.37 Moreover,
in 2012, glycodendrimers as functional antigens and anti-
tumor vaccines have been properly reviewed.38
In the current review, we have focused on the eﬀect of den-
dritic polymers on the structure of the prepared hybrid nano-
materials of graphene, carbon nanotubes (CNTs), metallic
nanoparticles and proteins/peptides via covalent–noncovalent
interactions. Indeed, we have revealed the newly observed
facets of dendritic polymers as transformers.
2. Dendritic polymers
Dendritic polymers are mostly globular macromolecules,
which have potential that cannot be concurrently found in
other materials. These polymers are almost the latest member
of the polymer family, whose name originates from the Greek
words ‘dendron’ meaning tree and ‘meros’ meaning part. In
1978, the first report on the synthesis of these nanomaterials
was published by Vogtle et al. in the synthesis of branched
polypropylene-amine ‘cascade molecules’. In the middle of
the 1980s, Tomalia et al.39 (Dow chemical company) and
Newkome et al.40 in parallel synthetic investigations reported
the synthesis of monodisperse poly(amidoamine) (PAMAM)
‘dendrimers’ and poly(ether-amide) ‘arborols’, respectively.
Thereafter, dendronization has always been considered as a
useful synthetic strategy for the preparation of multifunctional
materials.41–44 Nowadays, dendritic polymers have extensively
attracted scientists attention because of their unique merits in
biomedicine and biomedical backgrounds.
2.1. Structure
Dendritic polymers are a series of macromolecules, which syn-
thetically have a core accompanied by side branches. The core
may be a small organic molecule with the ability to form
several functional groups, or another macromolecule with a
high functionality. On the whole, from the structural view-
point, dendritic polymers can be classified in two major
groups: monodisperse frameworks such as dendrimers and
dendrons, and polydisperse frameworks including hyper-
branched polymers, dendrigrafts and linear-dendritic poly-
mers (Fig. 1).
Among all dendritic polymers, dendrimers are the most
important and most studied family. Dendrimers are defined as
globular, monodisperse polymers with three-dimensional
architectures, in which all the bonds radially emerge from a
central focal point (core) with repeating units that each
contribute to a branching point in the dendrimer (Fig. 2a).45
Dendrimers possess three distinguishable architectural
components: an interior core, interior layers (generations)
composed of repeating units radially attached to the interior
core, and exterior (terminal functionality) attached to the out-
ermost interior generation46 (Fig. 2b). The higher-generation
dendrimers, because of their globular structure, occupy a
smaller hydrodynamic volume compared to the corresponding
linear polymers. The dendritic scaﬀold may contain diﬀerent
types of functional groups such as secondary or tertiary
amines in the case of polyamidoamine that enable the entrap-
ment of drug molecules via hydrogen bonding, ionic bonding
or hydrophobic interactions. The outer layer possesses a
defined number of reactive functional groups that can be
modified to influence the valency, solubility, tissue binding,
and pharmacokinetics (e.g. PEG, PEGylation, acetylation, glyco-
sylation, and amino acid functionalization) or biodistribution
properties of the dendrimer (Fig. 2c). In addition, the surface
reactive groups may also be used to covalently attach the drug
molecules via labile chemical linkages (ester, amide, hydra-
zone, peptide, disulfide spacer.). Using these approaches, den-
drimers can be constructed with precise control over several
generations and surface functionalities, producing structures
with typically high monodispersity when compared to the syn-
thesis of traditional polymers, which typically produces stat-
istical mixtures of products.
Although dendrimers have a unique size and symmetric
structure with branching units without any structural defects,
the tedious stepwise procedure for dendrimers often results in
expensive products with limited availability, and therefore,
results in a restricted use for large-scale industrial appli-
cations. Unlike dendrimers, hyperbranched and dendritic
polymers are often easy to synthesize in a large-scale single-
step synthetic process, and therefore, are considered to be
Fig. 1 Schematic classiﬁcation of the dendritic polymers including two
major categories and their subgroups.
Fig. 2 (a, b) Representation of the layers or generations (G) of a dendri-
mer. (c) The surface may be composed of any appropriate functional
group.
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potential alternatives to perfectly branched dendrimers in the
field of engineering materials.47–49 However, the one-step pro-
cedures used for the preparation of hyperbranched polymers
lead to uncontrolled statistical growth. Consequently, the
resulting structures are imperfect and polydisperse. Further-
more, unlike dendrimers, the control over layers or gener-
ations, as well as over molecular weights deteriorates.
2.2. Toxicity
Although all the toxicity issues of dendrimers and solutions
for their prevention have been recently summarized in a review
paper,50 in this study, we briefly mention some key points. The
toxicity of dendrimers in biological systems is generally charac-
terized by hemolytic toxicity, cytotoxicity and hematological
toxicity. Generally, the in vivo toxicity of dendrimers is attribu-
ted to the surface cationic charge interactions of dendrimers
with negatively charged biological membranes, which can
result in membrane disruption via pore formation, membrane
thinning and erosion. To overcome or minimize this toxicity
two major strategies can be employed: (i) the design and syn-
thesis of biocompatible dendrimers via employing a bio-
degradable core and branching units or utilizing intermediates
of various metabolic pathways and (ii) masking of the periph-
eral cationic charge of dendrimers by the neutralization of
charge, for example PEGylation, acetylation, carbohydrate and
peptide conjugation, or by introducing negative charge such as
half-generation dendrimers. It has been shown that neutral
and negatively charged dendrimers do not interact with the
biological environment, and hence, are compatible for clinical
applications. Moreover, it has been reported that hydrophobi-
cally derivatized hyperbranched polyglycerol (PG) can be a suit-
able substitute for human serum albumin.51
3. Surface modiﬁcation of
nanomaterials with dendritic polymers
The prefix “nano”, derived from the Greek “nanos”, signifying
“dwarf”, is becoming increasingly common in scientific litera-
ture. Nano is now a popular label for modern science, and
several nano-words have recently appeared in dictionaries,
including nanometer, nanoscale, nanoscience, nanotechnol-
ogy, nanostructure, nanotube, nanowire, and nanorobot.52
Nanostructured materials are the core components of nano-
technology, providing basic building blocks for fabricating
complex devices with desired functions. Owing to their
inherent quantum size and shape eﬀects, nanomaterials have
several important applications in electronics, optoelectronics,
information processing, catalysis, biomedical science, environ-
mental science, energy conversion and storage, advanced
defence technologies, and various other fields.53 In the past
years, numerous novel hybrid nanomaterials have been develo-
ped for biomedical applications.54 Among the polymer
materials employed for surface modification of hybrid
nanomaterials, dendritic polymers have obtained significant
interest because of their interesting architecture and special
chemical and physical properties.55,56 Dendrimers and hyper-
branched polymers exhibit a highly branched, non-entangled
architecture and numerous terminal groups. They exhibit
considerably lower melt and solution viscosities and higher
solubility in comparison with their linear analogues. Hence,
dendrimers or hyperbranched polymers-functionalized nano-
materials even with a low functionalization degree are easier
to solubilize. The lower viscosity of the functionalized nano-
materials in a solution or the molten state will favour the
manipulation and processing of the nanohybrids. Further-
more, dendrimers and hyperbranched polymers can be advan-
tageously used as functional surface and interfacial materials.
The numerous terminal groups facilitate further modification
and can be covalently modified with some linear polymers or a
broad range of functional groups such as fluorophores, electro-
active groups, perfluorinated moieties, and dyes. On the other
hand, they can be used to entrap or stabilize various metal,
metal oxide and semiconductor nanoparticles. Therefore,
dendrimers and hyperbranched polymers are ideal materials
for the modification of nanomaterials.
4. Changing the structure of
nanomaterials by dendritic polymers
The main goal of this review is to study the whys and hows of
the impact of dendritic polymers on changing the structure of
other nanomaterials. For example, it has been shown that den-
dritic polymers are able to result in direct graphite delamina-
tion, the formation of CNTs and graphene nanocapsules,
prevention of amyloid formation and metallic nanoparticles
size control. Here, as a major part of the paper, we extensively
review the impact of dendritic polymers on graphenes, CNTs,
proteins/peptides and metallic nanoparticles.
4.1. Graphene
Graphene as a newly emerged carbon material has attracted
much attention because of its outstanding properties and a
wide range of fascinating applications. However, the mass pro-
duction problem has restricted its extensive use in industry.
The reduction from graphene oxide has been considered as
one of the potential procedures for mass-scalable preparation.
However, it suﬀers from restacking of the final graphene
sheets after reduction because of the strong intersheet inter-
actions. Recently, the utilization of dendritic polymers for
edge-functionalization of graphene has attracted considerable
attention. Because of their high solubility in solvents and
natural bulky nanostructures, dendritic polymers are able to
eﬀectively prevent restacking of graphene sheets and provide a
solution for the abovementioned problem. Although there are
numerous reports and review papers in the literature about the
synthesis and applications of nanomaterials based on gra-
phene in biomedical and biomedicine areas including drug
delivery,57–63 cancer therapy,62,64–68 non-viral-based gene
therapy,69,70 tissue engineering,48 cellular imaging,61,71 and
biosensors,62,72–74 its unique nature and inimitable properties
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have forced scientists in all fields to accelerate their researches
on this ‘magic’ material.
4.1.1. Covalent interactions. In one interesting work,
hyperbranched poly(ether-ketone) (HPEK) has been utilized
for the direct delamination of graphite into graphene and
graphene-like platelets in a one-step reaction.75 In this study,
carboxylic acid-terminated HPEK has been prepared via the
in situ polymerization of 5-phenoxyisophthalic acid as an AB2
monomer in PPA/P2O5 medium based on a direct Friedel–
Crafts acylation reaction. On the basis of the results obtained
from the wide-angle X-ray diﬀraction (WAXRD), scanning
electron microscopy (SEM), transmission electron microscopy
(TEM) and atomic force microscopy (AFM), it has been shown
that HPEK is selectively grafted at the edges of graphite to
produce HPEK-grafted graphite (HPEK-g-graphite), which
showed an edge-expanded flower-like graphene morphology in
the solid state and was readily dispersible in several polar sol-
vents (Fig. 3). The use of HPEK as dendritic polymer wedges
played an important role in the graphite delamination into
graphene and graphene-like platelets. The concept of edge-
selective grafting of graphite suggests an eﬃcient pathway to
prepare graphene and graphene-like platelets without basal
plane functionalization. This approach envisions that the edge
chemistry of graphite can be utilized to produce various
graphene-based nanomaterials with specific applications by
simple introduction of diverse functional molecular wedges.75
Indeed, because the solubility of dendritic polymers is signifi-
cantly higher than their linear analogues because of their
three-dimensional molecular architectures, they can aﬀect the
multi-laminated structure of graphite and cause its delamina-
tion to produce edge-functionalized graphene in a one-pot
one-step procedure without any vigorous oxidation reaction.
The enzymatic functionalization of graphene in certain
sites and with special patterns has been already reported.81
Because of the selectivity of enzyme pocket and also the
topology of graphene sheets; diﬀerent factors dominate the
pattern of the functionalization and properties of the final
hybrid nanomaterials. For example the functionalization of
graphene oxide by polyethylene glycol mediated by Novozyme
leads to hybrid nanomaterials possessing PEG on their
surface. However, the same method for the functionalization
of graphene but using citric acid as a substrate leads to
functionalized hybrid nanomaterials having hyperbranched
polycitric acid in circular shapes on their surface.76
In another report, a remarkable dendrimer size eﬀect on
the solubility and bulk electrical conductivity of dendronized
graphene has been extensively described.77 In this work, a one-
step covalent functionalization and simultaneous reduction of
graphene oxide (GO) with dendritic anilines (DnPhNH2) has
resulted in dendronized graphenes, named DnG, where n is
the generation number of the dendritic structure having a
value of 0–3 (Fig. 4). It is well known that the reduction from
GO is one of the potential method for the mass-scalable prepa-
ration of graphene. However, as mentioned earlier, it is
faced with the problem of graphene sheets restacking
after reduction. Surprisingly, Li et al.77 have found that
the graphene dendronization process not only hampers the
restacking of the final graphene sheets and significantly
increases their dispersity in a variety of organic solvents, but
also interestingly reinforces the bulk electrical conductivity
with an appropriate dendritic structure. The recovery of a
honey-like crystalline lattice and few-layer characteristics of
these dendronized graphenes have been revealed by the TEM
technique. As shown in Fig. 4, most of the sheets are trans-
parent and have a silk-like wrinkle. In some cases, folded layers
were observed. The well-defined six-fold symmetry patterns in
normal-incidence selected-area electron diﬀraction (SAED) for
Fig. 3 (A) Schematic representation of the direct delamination of
graphite; SEM images of (B) pristine graphite and (C) HPEK-g-graphite;
(D) AFM image (left) of HPEK-g-graphite with topographic height
proﬁles (right). Reproduced from ref. 75 with permission from the Royal
Society of Chemistry.
Fig. 4 (A) Schematic description of the synthesis of dendronized gra-
phenes; (B–E) TEM images of D0G, D1G, D2G, and D3G, respectively.
Insets show SAED patterns. Reproduced from ref. 77 with permission
from the Royal Society of Chemistry.
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all the samples are similar to that of liquid-exfoliated
graphene, demonstrating that the obtained dendronized
carbon nanosheets have good crystallinity. These observations
have demonstrated that most of the oxygen moieties have been
removed during dendronization and the crystalline lattice of
graphene has been re-established. Furthermore, the restacking
of graphene sheets in cases of D0G has occurred, while that
was rare for D2G and D3G, illustrating that a large dendritic
wedge can eﬃciently prevent the agglomeration of carbon
sheets. In addition, the AFM images of D1G, D2G, and D3G
have shown a film thickness of 1.1, 1.5, and 2.1 nm, respecti-
vely. These values are greater than the literature values for
single-layer GO, but in the range of chemically modified
graphenes.78–81 The increment in thickness as compared with
GO is reasonable when taking the bulky size of the dendritic
wedges into consideration. However, AFM of D0G has shown
aggregated objects in place of single flat sheets. This contrast
demonstrates the importance of bulky dendritic wedges in
suppressing the re-aggregation of the carbon sheets after
reduction. As a great achievement of this study, the dispersity
has shown a marked dependence on the size of the dendritic
structure, in which the larger dendritic substituents aﬀord
better dispersity. Surprisingly, dendronization with an appro-
priate size of dendritic structure does not reduce, but signifi-
cantly enhances the bulk electrical conducting capability.
Furthermore, another additional bonus of this dendronization
is that the final graphene products can be easily separated and
purified from the unreacted starting materials, reaction media,
and other impurities, simply by filtration and washing. More-
over, the final dendronized graphene products are solid
powders and can be redispersed in any desired organic sol-
vents. This feature is highly appealing for bulk production
because it is beneficial for storage and transportation. The
applications of these highly conductive and easily dispersed
dendronized graphenes in reinforced composites and opto-
electronic devices are worthy of further investigation.77
The functionalization of graphene by biopolymers and pro-
teins such as albumin to produce anticancer drug delivery
systems has been reported. The conjugation of albumin onto
the surface of graphene by a PEG linker leads to globular
hybrid nanomaterials, which are able to transfer anticancer
drugs, such as paclitaxel, both by the graphene surface and
the albumin cavity.82
4.1.2. Noncovalent interactions. Recently, a research group
has indicated that the reaction between PAMAM-G4 dendrimer
and silanized GO could be resulted in formation of crumpled
PAMAM-Sil-rGO structures (Fig. 5). For the preparation of
these crumpled PAMAM-Sil-rGO structures, first graphene
nanoparticles have been prepared through a two-step synthetic
approach. In the first step, GO was enriched with reactive
epoxy groups by treatment with (3-glycidyloxypropyl)trimethox-
ysilane, using the hydroxyl groups on the nanomaterial surface
as anchoring points. Subsequently, silanized graphene oxide
(Sil-GO) was modified with the polyaminated dendrimer mole-
cules through the formation of stable secondary amine lin-
kages, yielding a dark product that was easily dispersed in
aqueous solutions (PAMAM-Sil-rGO).83 In addition, TEM
images of the PAMAM-Sil-rGO nanomaterial confirmed that
GO sheets were crumpled into three-dimensional nano-
structures after covalent modification with the dendrimer.
The shape of these nanomaterials varied from compact
nanoparticles to less ordered structures, in which pendant and
wrinkled graphene sheets were observed in some cases. In
addition, some partially creased graphene sheets were also
detected. The graphene nanoparticles showed high polydisper-
sity with a diameter distribution ranging from 100 nm to
850 nm, and with a peak size of 420 nm. Moreover, the mor-
phology of the nanoparticles was also studied by the FESEM
technique. The crumpled morphology of the PAMAM-Sil-rGO
nanoparticles was confirmed, but it was also revealed that they
can be formed either by crumpling of a single graphene sheet
or by the association of several of these nanomaterials. In
some cases, it seems that a single graphene sheet can be
involved in the formation of two or more nanoparticles yield-
ing larger and more complex condensed structures. This fact
can contribute to the high size polydispersity exhibited by the
crumpled nanostructures. It should also be noted that gra-
phene oxide prepared by Hummers method is a highly poly-
disperse material, with sheets ranging from a hundred
nanometers to several micrometers in size. Thus, the pro-
duction of crumpled nanostructures with a great variety of
diameters can be expected.83
In addition, in one of our newest researches, we have selec-
tively functionalized graphene sheets from the edges by hyper-
branched polyglycerol (HPG) having a polycyclic focal point.84
Surprisingly, edge-functionalized graphenes have the capa-
bility of forming self-assembled nanocapsules in aqueous solu-
tions, because of the hydrophilicity of their functionalized
edges and hydrophobicity of their flat surface. These nano-
capsules are able to eﬃciently deliver hydrophobic molecules
such as anticancer drugs, e.g. doxorubicin (DOX). For the
preparation of our considered HPG-based dendritic polymer,
we arranged a set of reactions for our macromolecular architec-
ture. On the basis of the plan, first, a tricyclic molecule was
synthesized by a nucleophilic substitution reaction between
Fig. 5 Schematic display of the steps involved in the preparation of
PAMAM-Sil-rGO. AFM and section analysis for (A) GO, (B) Sil-GO and (C)
PAMAM-Sil-rGO. Reproduced from ref. 83 with permission from the
Royal Society of Chemistry.
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cyanuric chloride and naphthol. Then, the third chlorine sub-
stitute of the triazine moiety of 2-chloro-4,6-dinaphthoxy-1,3,5-
triazine was replaced by diethanolamine and 2-diethanol-
amino-4,6-dinaphthoxy-1,3,5-triazine (DDT) was obtained
(Fig. 6A). Then, DDT was used as a macroinitiator in the
anionic ring-opening polymerization of glycidol and DDT-g-
HPG (DDTP) was synthesized. As can be seen from Fig. 6, by
changing the angle between naphthol(s) and triazine rings,
many conformations for the aromatic focal point of DDTP are
possible, when it is interacting with graphene sheets. However
two extreme cases are B and C, which are shown in Fig. 6.
All other cases lie between these two cases. Actually, case B
explains the sandwiching of the graphene edges by the
polymer, whereas case C shows the stacking of the focal point
of DDTP onto the surface of graphene. Additionally, we have
visually indicated that HPG with a bidentate aromatic segment
in its focal point, DDTP, is able to interact with graphene
edges and form self-assembled nanostructures (Fig. 6D).
Because of the hydrophobicity of the flat surface of the edge-
functionalized graphenes and hydrophilicity of their edges,
they changed their conformation from the extended to the
closed state and formed nanocapsules in aqueous solutions.
Spectroscopy and microscopy evaluations showed that the
average size of nanocapsules is 300 nm. The aqueous solutions
of nanocapsules and those with encapsulated doxorubicin
were stable at room temperature for several weeks.72 In
addition, we have demonstrated that DDTP-G-DOX is globular
and its size is around 400 nm. TEM images not only confirm
the functionalization of graphene by DDTP from the edges,
but also display a new conformation for edge-functionalized
graphenes in aqueous solutions.84
Moreover, hyperbranched polymeric ionic liquids (hyper-
PILs) having C18 aliphatic chains with onion-like topology have
been synthesized and employed for dispersing functionalized
graphene (FG) in toluene.85 FG, prepared by the thermal
reduction of graphite oxide, is readily dispersed in polar
solvents by high-pressure homogenization, and mainly forms
single FG nanosheets.86 In the presence of C18-hyper-PILs,
stable FG dispersions have been formed in nonpolar media,
such as toluene, whereas the dispersions of FG in pure toluene
undergo rapid sedimentation. In fact, the interactions between
the C18-hyper-PILs dendritic polymer and FG nanosheets have
resulted in a hybrid nanomaterial, which is highly soluble in
nonpolar solvents.
In addition to the interactions between graphene sheets
and dendrimers, the driving forces of conformational changes
in single-layer graphene oxide have interestingly been studied.
It has been indicated that single-layer graphene oxide (SLGO)
in the wet state is dried from the wet state, and in the dry state
exhibits very diﬀerent textural characteristics that are governed
by the chemical environment, at particular pH, as well as its
oxygen-containing functional groups and their surface charge.
At basic pH, SLGO sheets tend to fold owing to the electro-
static repulsion between negatively charged deprotonated
acidic groups, and SLGO suspensions are stable, whereas at
low pH, SLGO suspensions are destabilized owing to stronger
intersheet interactions. Upon drying, SLGO sheets form dense
aggregates with complex structure and porosity, and low BET
surface area. Depending on the geometric size of SLGO sheets
and the drying conditions, they can unfold or remain folded
because of the hydrogen bonding between polar surface
functional groups and dispersion interactions between non-
polar graphene fragments. Therefore, a careful selection of the
chemical environment and the surface functionality and reac-
tivity of single-layer graphene oxide sheets is required when
tailoring SLGO for specific applications.87 Overall, it is well
known that SLGO sheets undergo morphological changes
depending on the pH of the system and this may account for
their restricted chemical reactivity. They can also capture
nanoparticles through layering and enveloping when the pH is
changed, demonstrating potential usefulness in drug delivery
or waste-material capture.88
4.2. Carbon nanotubes (CNTs)
4.2.1. Covalent interactions. Dendritic polymers including
a series of dendritic β-D-galactopyranosides and α-D-manno-
pyranosides,89,90 poly(propyleneimine) dendrimer (PPI),91
polycationic dendrons,92 poly(amidoamine) dendrimer
(PAMAM)93,94 and dendron,95 polyglycerol (PG),96,97 poly(citric
acid) (PCA),98–100 poly(citric acid-co-D-sorbitol) (PCAS),101
hyperbranched poly(ether-ketone) (HPEK),102 hyperbranched
polyethylene (HBPE),103 hyperbranched p-chloromethyl-
styrene,104 hyperbranched phenolic polymer (HBP),105,106 hyper-
Fig. 6 (A) Schematic representation of the synthesis of DDTP, (B and C)
schematic representation of two extreme conformations for naphthol
rings in the focal point of DDTP when it is interacting with the surface of
graphene, (D) interactions between graphene sheets and DDTP to
produce globular shapes, and (E) TEM image of the nanocapsules with a
hydrophobic core and hydrophilic shell and hydrophobic graphene
sheet. Reprinted from ref. 84 Copyright (2013) with permission from
Elsevier.
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ene)vinylene] (PmPV),107 and poly(3-O-methacryloyl-α,β-D-
glucopyranose) hyperbranched glycopolymers108 have been
covalently/noncovalently conjugated onto the surface of CNTs
to eﬃciently modify their surface.
In our research group, we have extensively grafted hyper-
branched PCA and PG as highly biocompatible polymers on
the MWCNTs surface to produce nanomedicines.96,98,100,109–111
In another research, we synthesized MWCNT-g-PCA-PTX as a
highly eﬃcient anticancer drug delivery system. Surprisingly,
during the functionalization of MWCNTs by PCA, the confor-
mation of the nanotubes changed from a linear toward a circu-
lar type because of secondary interactions between PCA
macromolecules (Fig. 7).99 This system is one of the most sur-
prising, and the first system observed by our group in which
CNTs cannot be found in their extended conformation and the
drug delivery system is in the form of nanoparticles. TEM and
AFM images show that functionalized CNTs are agglomerated
to form bigger nanoparticles. Because CNTs are functionalized
by PCA branches that have numerous carboxyl functional
groups on their surfaces, hydrogen bonds between the periph-
eral functional groups of these branches are the major driving
force and the main secondary interaction to make globular
shapes from CNTs.
Next, the cytotoxicity of MWCNT-g-PCA-PTX nanomaterials
against SKOV3 ovarian cancer cells and A549 lung cancer cells
has been evaluated. The results of cytotoxicity assays demon-
strated that MWCNT-g-PCA-PTX exhibits a higher cytotoxic
eﬀect compared with unconjugated paclitaxel, which can be
attributed to increased cell penetration.
Moreover, pristine MWCNTs were opened and functiona-
lized by a treatment with acid and HPG was covalently grafted
onto their surface by the “grafting from” approach based on
the anionic ROP of glycidol monomers. TEM images show that
PG is grown onto the tip of carbon nanotubes more than other
regions where more hydroxyl functional groups, initiators for
the polymerization of glycidol, are created upon treatment
with acid. When the surface of carbon nanotubes is covered by
polymers, especially in the case of the “grafting from” method
in which the density of polymerization onto the surface of
CNTs is higher, the physicochemical properties of carbon
nanotubes and their interactions with biological systems are
dominated by polymers. In this work the death of cells incu-
bated with MWCNT-g-HPG and other interactions with cells
have been investigated and it can be found that polyglycerol
directly aﬀects all these interactions. In vitro cytotoxicity tests
and hemolysis assays did not show any adverse eﬀects on
HT1080 cells and red blood cells. The functionalization of
CNTs with HPG decreases their in vitro cytotoxicity and makes
them promising nanomaterials in nanomedicines.96 Although
diﬀerent analyses and other observations in several works
show that polymers attached onto the surface of CNTs domi-
nate their biological properties, carbon nanotubes retain their
own properties in these systems and actually the properties of
these systems originate from all segments, but with diﬀerent
priorities. For example, in the case of MWCNT-g-HPG, toxicity
is controlled by the polyglycerol shell, whereas carbon nano-
tubes have a large eﬀect on the rate of transfer of the system
from the cell membrane such that most of the system is trans-
ferred from the cell membrane in one hour.
4.2.2. Noncovalent interactions. Noncovalent interactions
between cisplatin/poly(citric acid)-poly(ethylene glycol)-poly-
(citric acid) (CDDP/PCA-PEG-PCA) anticancer prodrugs and
CNT/γ-Fe2O3 NP hybrid nanomaterials have resulted in the
preparation of CDDP/PCA-PEG-PCA/CNT/γ-Fe2O3 NPs anti-
cancer drug delivery systems.112,113 There are several key fea-
tures of these hybrid drug delivery systems: (i) their ability to
cross cell membranes and also high surface area per unit
weight for the high drug loading, attributed to CNTs, (ii) high
functionality, water solubility and biocompatibility attributed
to PCA-PEG-PCA linear-dendritic copolymers and (iii) targeting
tumors using a magnetic field attributed to γ-Fe2O3 NPs. The
eﬃcacy of drug delivery systems for killing cancer cells and tar-
geting the drugs towards tumors has been investigated. Inter-
estingly, in this work a 100 mg mL−1 concentration of the final
NDDSs has killed more than 95% of cancer cells in vitro. These
nano-objects are completely soluble in water at diﬀerent pHs
and their aqueous solutions are stable over several months.
The selective delivery of CNTs to tumor cells, minimizing their
side eﬀects, can be achieved by simultaneously anchoring iron
oxide nanoparticles and PCA-PEG-PCA copolymers to their
surface followed by an external magnetic field. It was found
that these interactions led to changes in the conformation of
CNTs from strand-type toward liposome-like nanocapsules
(LLNs).114
Here, the linear-dendritic copolymer is fully hydrophilic
despite of other works in which at least one of the polymer
segments should be hydrophobic. Therefore, the types of sec-
ondary interactions between the linear-dendritic copolymers
and CNTs were investigated by diﬀerent thermal analysis and
spectroscopy methods. It has been found that hydrogen
bonding between the functional groups of linear-dendritic
copolymers and hydroxyl groups created on the surface of
CNTs, or on the surface of iron oxide nanoparticles attached to
the surface of CNTs, is a type of eﬀective secondary interaction
between these two segments. Spectroscopy investigations have
proved that interactions between the π system of carbonyl
groups of linear-dendritic copolymers and CNTs are another
type of interactions, which attach copolymers to CNTs.
An eﬀective method to incorporate cadmium selenide
(CdSe) nanoparticles with diﬀerent capping agents onto the
surface of f-MWCNTs has been developed. In this work, CdSe
Fig. 7 (A) Scheme of MWCNT-g-PCA and (B, C) phase contrast AFM
images of MWCNT-g-PCA-PTX donut-shaped conjugates. Reprinted
from ref. 99 Copyright (2011) with permission from Dove Press.
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NPs with negative and positive surface charges were syn-
thesized using thioglycolic acid (TGA) and gelatin capping
agents, respectively. Then, they were deposited onto the
surface of MWCNTs using linear-dendritic ABA-type block
copolymers containing polyethylene glycol as B blocks and
poly(citric acid) as A blocks, PCA-PEG-PCA. This method led to
hybrid nanomaterials consisting of well-dispersed CdSe NPs
on the surface of MWCNTs, whereas the deposition of CdSe
NPs onto the surface of MWCNTs without linear-dendritic
copolymer intermediates, directly, resulted in the agglomerates
of CdSe NPs in some areas on their surface.115
For the first time, we proved that polymers not only raise
the functionality, biocompatibility and water solubility of
CNTs but also are able to dramatically change the CNTs con-
formations. Diﬀerent spectroscopy methods, such as NMR, IR
and DLS, together with microscopy images proved that there
are strong interactions between CNTs and linear-dendritic
copolymers. It was clear that polar interactions are among the
most eﬀective driving forces at changing the conformation of
CNTs. It means eﬀective secondary interactions among poly-
mers lead to changes in CNTs morphology.96,97,116 It has been
observed that interactions between polyglycerol-poly(ethylene
glycol)-polyglycerol (PG-PEG-PG) ABA linear-dendritic copoly-
mer and CNTs lead to the conformation alteration of CNTs
from the extended toward the closed state because of lipo-
some-like nanocapsules formation (Fig. 8). On the other hand,
DLS experiments showed that the size of CNTs dramatically
decreased upon interactions with linear-dendritic copolymers,
which again proves the changes in the conformation of CNTs
from extended toward globular. Because one of the proposed
reasons for the carcinogenicity of CNTs is their long lengths
and rigid structures, flexible liposome-like nanocapsules pre-
pared by this strategy could be safer and far from the asbestos-
like physicochemical properties of CNTs. In this research, the
biocompatibility of liposome-like nanocapsules and their
ability to load and deliver anticancer drugs such as doxorubi-
cin (DOX) have been evaluated and it has been proved that
their loading capacity is more than two grams of drug to one
gram of liposome-like nanocapsules.117
PG-PEG-PG ABA linear-dendritic copolymer is a fully hydro-
philic compound and consists of a backbone with C–O bonds
and peripheral hydroxyl functional groups. Therefore, inter-
actions between the copolymer and the π system of CNTs or
hydrophobic interactions between these two segments
should not be significant factors in this case. Hydrogen
bonds between hydroxyl functional groups of CNTs and the
PG-PEG-PG ABA linear-dendritic copolymer are the main
driving force to not only attach the copolymer onto the surface
of CNTs but also change the conformation of CNTs toward a
globular shape.118
In one of our recent works, noncovalent interactions
between poly (amidoamine)-poly(ethylene glycol)-poly(amido-
amine) (PAMAM-PEG-PAMAM) ABA type linear-dendritic co-
polymers and CNTs and changes in the conformation of CNTs
upon these interactions have been extensively investigated.
The modification of the end functional groups of these copoly-
mers leads to a hybrid nanomaterial containing CNTs with a
copolymer shell in which CNTs retain their rigid structure. It
has been shown that π–π stacking dominates interactions
between the linear-dendritic copolymer and CNTs in this case,
such that in the defect sites stacked copolymer was not
observed at all. However, when PAMAM-PEG-PAMAM was not
modified, π–π interactions between the carbonyl functional
groups of the copolymer and the π system of CNTs were the
most eﬀective factor in attaching the copolymer onto
the surface of CNTs, while the secondary interactions between
the end amino functional groups of the dendritic block of the
copolymer force CNTs to change their conformation from a
strand type to a packed form (Fig. 9).119
However, by changing the conditions, secondary inter-
actions lead to other types of hybrid nanomaterials with extre-
mely diﬀerent topology. For example interactions between
PAMAM-PEG-PAMAM linear-dendritic copolymers modified by
4,6-diphenoxy-1,3,5-triazine with carbon nanotubes result in
supramolecular ultra-long carbon nanotubes, which are
suggested as promising candidates to avoid the asbestos-like
health risk of this type of nanomaterials.120
It has been demonstrated that methylated β-cyclodextrins
(CDs) modified by a triazole group, itself substituted by
highly hydrophilic moieties, such as sulfonate or hydroxyl
groups, can constitute a new class of MWCNT dispersing
agents via noncovalent interactions.121 TEM captured images
of CDTSO3Na-MWCNT have also displayed a coil structure of
carbon nanotubes, which can be correlated to the secondary
molecular interactions among CDTSO3Na segments.
Moreover, recently, PAMAM dendrimer has been used as a
crosslinker to produce magnetic carbon nanotube aerogels.122
For this synthesis, acid-treated MWCNT, amino-terminated
generation 5 PAMAM dendrimer, gluconolactone (GDL) and
magnetic Fe3O4 colloidal suspension have been used. With the
help of the hydrolyzed product of the GDL to decrease the pH
value of the mixture, in situ protonated PAMAM dendrimer
was connected with carboxyl groups attached to diﬀerent
Fig. 8 (a) schematic representation of noncovalent interactions
between linear-dendritic copolymers and surface of CNTs that lead to
new hybrid nanomaterials with improved properties (b) AFM image of
PG-PEG-PG/MWCNT liposome-like nanocapsules containing encapsu-
lated DOX molecules. The highlighted object in the top-left part of the
image, by a black line, shows the MWCNTs. Reprinted from ref. 114 with
permission from the Royal Society of Chemistry.
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MWCNTs via electrostatic interactions to generate aerogels
after either supercritical CO2 drying or freeze-drying.
4.3. Nanoparticles
In one of the rarest reports related to the impact of dendritic
structures on nanoparticles, Yan et al. have described a strat-
egy for the synthesis of gold nanoparticles (Au-NPs), for which
the size and surface reactivity of the particles are controlled by
the molecular sizes of dendritic arenethiols (DAT) as capping
agents. This strategy exploits two important attributes of the
DAT molecules: one involving the utilization of the umbrella-
like structure with a single thiol as the anchorage handle and
the other involving the rib with an expandable dendritic struc-
ture as a spacing-tunable cap. The synthesis of Au-NPs with
controllable sizes below 10 nm has been demonstrated using
diﬀerent sizes of DAT in both one-phase and two-phase solu-
tions. The unique structural properties of the dendritic are-
nethiol capping molecules not only provide the ability to
control the size growth of Au-NPs but also a ready surface
exchange reaction for surface derivatization and interparticle
assembly. The viability of this strategy for the control of size
and surface reactivity has been demonstrated by results from
structural and morphological characterizations of the nano-
particles and assemblies (Fig. 10).123
The combined impact of these results has demonstrated
the feasibility of exploiting the molecular sizes of dendritic
arenethiols (DAT) as capping agents for the control of the size
and surface reactivity of Au nanoparticles. This type of con-
trollability was achieved by the unique umbrella-like structure
of DATs with a single thiol as the anchorage handle and the
rib having an expandable dendritic structure as a spacing-
tunable cap. This structure was shown to eﬀectively tune the
surface reactivity, as evidenced by the easy replacement of the
Fig. 9 Molecular structure of (a) PAMAM-PEG-PAMAM ABA-type
linear-dendritic copolymers and (b) PAMAM-PEG-PAMAM linear-dendri-
tic copolymers modiﬁed by 4,6-diphenoxy-1,3,5-triazine. (c and d) sche-
matic interaction of macromolecule ‘a’ and macromolecule ‘b’,
respectively, (e and g) AFM and TEM images of CNTs interacting with
macromolecule ‘a’ and (f and h) AFM and TEM images of CNTs interact-
ing with macromolecule ‘b’. Reprinted from ref. 119 with permission
from the Royal Society of Chemistry.
Fig. 10 (A) Illustration of the exploitation of umbrella-like DAT mole-
cules by the utilization of the structure with a single thiol as the ancho-
rage handle and the rib with an expandable dendritic structure as a
spacing-tunable cap for tuning the nanoparticle sizes and surface reac-
tivity, (B) structures of the dendritic arenethiols and their corresponding
TEM micrographs and size distributions for DAT-capped Au-NPs (syn-
thesized by two-phase method) after ligand exchange with decan-
ethiols. Reproduced from ref. 123 with permission from the Royal
Society of Chemistry.
Review Polymer Chemistry


































DAT molecules by a ligand having a stronger binding ability to
the gold surface than DAT. One important aspect of this struc-
tural character for size control is the dependence of the
binding strength of DATs to gold particles on the “umbrella
rib” size, which leads to the capability of controlling the
particle sizes. Another important aspect is the combination of
the interparticle weak interactions and voids that facilitate the
surface reactivity and interparticle assembly by molecular
linkers.
Molecular self-assembly of quantum dots and metal nano-
particles mediated by polyrotaxanes to produce new nano-
objects has also been previously observed by our groups.124–126
Furthermore, a simple and eﬀective non-lithographic
method for the preparation of a novel organization of noble
metal nanoparticles into horseshoe-like nanostructures via
self-assembly has been studied.127 The adsorption of Au nano-
particles stabilized with the dendrimer 1,2,3,4,5,6-hexakis-
[(3′,5′-bis(benzyloxy)benzyl)sulfanylmethyl] benzene (S6G1) on
hydrophilic surfaces has resulted in the formation of spatially
correlated droplet aggregates. The annealing of Au/S6G1 in
thin films has caused amalgamated droplets to form arrays of
horseshoe-like nanostructures with an average size of 250 nm
and an average height of 13 nm (Fig. 11). The mobility and the
manner in which the semi-capped Au nanoparticles are dis-
tributed on the hydrophilic substrate are believed to be the
promoters that control the growth of the nucleation to create
the horseshoe-like structures. Atomic force microscopy (AFM)
measurements demonstrated the changes in height and size of
the nanoparticles before and after the annealing process.
Oxygen plasma etching has been used to remove the S6G1 den-
drimer to reveal the orientation of the Au nanocrystals in the
nanostructure matrix. The results of this research have been
comparable to the results obtained by Nolte and co-workers128
on the formation of the ring-like structures of porphyrin
molecules.
Moreover, PCA-PEG-PCA linear-dendritic copolymers have
been used as capping and reducing agents to produce gold
nanoparticles. Because there are two blocks in the structure of
copolymers, which can interact with the surface of the pre-
pared gold nanoparticles, necklace-type gold nanoparticles
could be obtained by this procedure.129 In addition, it has
been indicated that host–guest interactions between linear
polymers or alkyl chains and dendritic polymers with cyclodex-
trin moieties can result in globular soft nanoparticles with
interesting properties. For example polyglycerol (PG) with a
cyclodextrin in its focal point (CD-PG) associates with alkyl
chains with a guest molecule in their focal point to produce
nanoparticles as pH- and thermosensitive anticancer drug
delivery systems.130 Host–guest interactions between the
phenyl rings of polystyrene and CD-PG also lead to soft globu-
lar nanoparticles.131
5. Impact on proteins and peptides
The formation and accumulation of amyloid fibrils is a patho-
logical feature of more than two dozen clinical syndromes.
Thus, the inhibition of fibril assembly is a potential thera-
peutic strategy in neurodegenerative disorders such as prion
and Alzheimer’s diseases. It has been proved that dendrimers
are able to interact with amyloids as anti-amyloidogenic
agents. Amyloid fibrils are formed from a large number of
diﬀerent proteins and peptides that share the property
of adopting a crossed β-sheet conformation under particular
conditions.132 PAMAM, PPI and phosphorus dendrimers, as
well as glycodendrimers have been shown to be able to modu-
late amyloid formation.
In 2006, the impact of three generations (3rd, 4th, and 5th)
of PAMAM dendrimers on their activity against amyloid fibril
aggregation was investigated. In that research, Klajnert et al.133
reported the anti-amyloidogenic eﬀect of PAMAM dendrimers
on amyloid formation of the prion peptide PrP (185–208) and
the Alzheimer’s peptide Aβ (1–28). The results have shown
that the higher the dendrimer generation, the larger the
degree of inhibition of amyloid formation and the more
eﬀective are dendrimers in disrupting the already existing
fibrils. In addition, a hypothesis on a dendrimer–peptide inter-
action mechanism has been suggested based on the dendri-
mers’ molecular structure and TEM images.133
Recently, PPI dendrimers decorated with maltose (Mal) as
glycodendrimers with low intrinsic toxicity have demonstrated
great capacity to interfere with Alzheimer’s amyloid peptide Aβ
(1–40) fibrilization. It has been indicated that the interactions
between PPI-Mal glycodendrimers and peptides are gene-
ration-dependent. PPI-G5-Mal blocks amyloid fibril formation
generating granular non-fibrillar amorphous aggregates,
whereas PPI-G4-Mal generates clumped fibrils at low dendri-
mer–peptide ratios and amorphous aggregates at high ratios.
Both PPI-G4-Mal and PPI-G5-Mal are found to be nontoxic to
PC12 and SH-SY5Y neuronal cell lines. PPI-G4-Mal reduces
amyloid toxicity by clumping fibrils together, whereas amor-
phous aggregates are toxic to PC12 cells. The results have
shown that glycodendrimers are promising nontoxic nano-
materials in the search for anti-amyloidogenic agents (Fig. 12).134
Fig. 11 (A) Schematic representation of the mechanism of the for-
mation of the horseshoe-like structures during the annealing process.
The aﬃnity of the dendrimer molecules to each other and the surface
energy of the Au nanoparticles determine the structure formation, (B)
AFM height image of Au/S6G1 on the Si/SiO2 substrate after annealing at
140 °C. Insets: 3D horseshoe structures and higher magniﬁcation image
of a cross-section of the horseshoe structure. Reproduced from ref. 127
with permission from the American Chemical Society.
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Moreover, two structurally distinct maltose shell-modified
5th generation (G5) poly(propylene imine) (PPI) glycodendri-
mers fluorescently labeled (a) with open maltose shell, cationi-
cally charged G5-PPI-OS and (b) with dense maltose shell and
nearly neutral G5-PPI-DS, have been tested in relation to
several melanoma cell lines. It has been found that three mela-
noma cell lines internalize the G5-PPI-DS structure more
eﬃciently than non-tumoral HEK297 T cells. Furthermore, the
internalization pathways of G5-PPI-OS and G5-PPI-DS are
characteristic for each tumour cell phenotype and include
more than one mechanism. As a general trend, large amounts
of both G5-PPI-OS and G5-PPI-DS are internalized on a chol-
esterol-dependent pathway in MJS primary melanoma cells and
on non-conventional pathways in SK28 metastatic melanoma
cells. G5-PPI-OS, temporarily retained at the plasma mem-
brane in both cell lines, is internalized slower in the metastatic
than in the primary phenotype. Unlike G5-PPI-OS, G5-PPI-DS
is immediately endocytosed in both cell lines. The unconven-
tional internalization pathway and traﬃcking, exclusively used
by G5-PPI-DS in metastatic cells, is described at the molecular
level. The decay kinetics of fluorescently labeled G5-PPI-OS
and G5-PPI-DS is distinct in the two cellular phenotypes.
Both cationic and neutral maltose G5-PPI glycodendrimeric
structures represent molecules based on which design of new
formulations for therapy and/or diagnosis of melanoma can be
further developed.135
Moreover, the impact of heparin (a highly sulfated glycos-
aminoglycan, which is widely used as an injectable anti-
coagulant) and PAMAM-G3 dendrimers on the aggregation of
two amyloid peptides related to Alzheimer’s and prion dis-
eases have interestingly been studied. The obtained data have
clearly shown that the Aβ (1–28) and PrP (185–208) aggregation
processes have been individually enhanced by heparin and
PAMAM-G3 dendrimers, which modulate the aggregation
process by aﬀecting the nucleation rate at low concentrations
and the elongation rate at high concentrations.136 It is well
known that the inhibition of fibril assembly is a potential
therapeutic strategy in prion diseases. on the basis of this, the
eﬀect of cationic phosphorus dendrimers on the aggregation
process of the prion peptide PrP (185–208) has been studied.
The results have shown that the fourth generation of phos-
phorus dendrimers are able to clearly interfere with the PrP
(185–208) aggregation process by both slowing down the for-
mation of aggregates (by causing a decrease in the nucleation
rate) and by lowering the final amount of amyloid fibrils, a
common hallmark of conformational diseases.137
Furthermore, the eﬀect of pH on the amyloid inhibiting
activity of PPI dendrimers at the molecular level has also been
evaluated. As mentioned earlier, the formation of amyloid
plaques is a key pathological event in neurodegenerative dis-
orders, such as prion and Alzheimer’s diseases. The ionization
state of acidic and alkaline residues in prion and Alzheimer’s
peptides plays an important role in interactions between den-
drimers and peptides, which can result in an enhancement or
a decrease in the peptide amyloidogenicity. Our results can
help to establish the conditions for which dendrimers are
eﬀective inhibitors. These conditions are diﬀerent for PrP
(185–208) and Aβ (1–28) and strongly depend on the amino
acid sequence. The studies show that dendrimers can serve as
a tool to study the mechanism of formation of amyloid-like
structures and to generate useful knowledge for the design of
compounds with therapeutic utility.138
It has been demonstrated that electron paramagnetic reson-
ance (EPR) is a useful approach to monitor interactions
between dendrimers and proteins. Spin-probe and spin-label
techniques were used to study the interactions of the Aβ (1–28)
peptide involved in Alzheimer’s disease and the PrP (106–126)
peptide suspected to be preferentially involved in spongiform
encephalopathies with three diﬀerent types of PAMAM dendri-
mers. A computer-aided EPR analysis of a positively charged
and a neutral spin probe was performed by comparing the
pure dendrimer and peptide systems with the dendrimer–
peptide ones. Moreover, spin-labeled PAMAM dendrimers were
Fig. 12 Graphic schematically representing the morphology of the
diﬀerent dendrimer-amyloid aggregated species and the interactions
that can explain their formation. (A) Nucleation-dependent polymeriz-
ation process of Aβ (1–40): monomeric peptide (◊) assembles as lower-
and higher-molecular-weight peptide oligomers (○) (rapid formation
under our experimental conditions); preﬁbrillar structures form by com-
bination of peptide oligomers (○○○) and ﬁnally convert into ﬁbrils (□□).
(B) In the presence of PPI-G4-Mal dendrimer at low dendrimer–peptide
ratios, the interaction of the dendrimer with the monomeric peptide
does not prevent the formation of preﬁbrillar and ﬁbrillar structures but
the ﬁbrils are clumped, possibly glued together by the dendrimer. (C)
PPI-G4-Mal at high dendrimer–peptide ratios does prevent the for-
mation of preﬁbrillar structures by interfering with oligomer formation
(the dendrimer can interfere by interacting with the peptide monomers,
small oligomers and big oligomers) forming dendrimer–peptide oligo-
mer complexes that combine in the form of granular non-ﬁbrillar amor-
phous aggregates. (D) PPI-G5-Mal is able to alter the peptide oligomeric
structures (probably due to its capacity to form a higher number of
hydrogen bonds per dendrimer) even at low dendrimer–peptide ratios,
impeding in this way the formation of preﬁbrillar structures and leading
to the formation of amorphous aggregates. Reproduced from ref. 137
with permission from the American Chemical Society.
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used to test the interactions. The results show the interactions
between dendrimer and peptide monomer to be stronger for
Aβ (1–28) than for PrP (106–126). PAMAM dendrimers perturb
the aggregation of the peptides more than PPI dendrimers.
The Alzheimer’s peptide Aβ (1–28) and prion peptide PrP
(185–208) when exposed to destabilizing factors (for instance
adding heparin and lowering pH) form fibrils. In a preceding
study using fluorescence, it was revealed that the dendrimers
are able to prevent peptide aggregation. A probable mechan-
ism is that the dendrimers interact with peptide monomers,
and therefore, inhibit their capability of growing into fibrils.
Then, to understand the mechanism of inhibition of the aggre-
gation process, we have studied the peptide–dendrimer inter-
actions using EPR. In this report, aggregate-free (without
heparin and at neutral pH) Aβ (1–28) and PrP (106–126) (this
sequence is suspected to be preferentially involved in spongi-
form encephalopathies) were allowed to interact with the three
diﬀerent types of dendrimers: PAMAM dendrimers (5th and
6th generations), PPI dendrimers (G3) and P-dendrimers (G4).
Both spin-probe (the neutral TOH and the positively charged
CAT1 spin probes were used) and spin-label (the PAMAM den-
drimers were labeled with a nitroxide radical) techniques were
used to monitor the peptide–dendrimer interactions. The com-
puter-aided analysis of the EPR spectra at 255 K provided
information on the type and strength of interactions occurring
in the diﬀerent systems. The EPR analysis showed that Aβ
(1–28) has a dipolar interaction with the dendrimers prevent-
ing the separation of the probes in the form of aggregates at
255 K. Part of the probes interact with the peptide, but this
interaction is perturbed by the addition of the dendrimers.
Another part of the probes are free, captured in the hydration
layer at the dendrimer–peptide interface. The mobility and the
relative amount of the interacting and the free component,
obtained from spectral computation, change as a function of
the dendrimer type, indicating a stronger interaction with
PAMAM dendrimers, which are therefore suspected to func-
tion better as peptide aggregation scavengers with respect to
the other dendrimers. Furthermore, the use of spin-labeled
PAMAM dendrimers supported the finding of dipolar inter-
actions between these dendrimers and Aβ (1–28). The inter-
actions of the dendrimers with PrP (106–126) are weaker than
with Aβ (1–28). TOH showed stronger interactions than CAT1,
indicating that the interactions arise from polar and low-polar
groups. In this case too, the PAMAM dendrimers showed a
relatively stronger binding with this peptide. The labeled den-
drimers also show a weaker interaction of the dendrimers with
PrP (106–126) than with Aβ (1–28).139
Recently, the kinetics of amyloid and prion fibril formation
in the absence and presence of dense-shell sugar-decorated
dendrimers has been investigated. PPI dendrimers at gene-
ration 5 (G5) with a dense shell of maltose and maltotriose
units have been employed for this assessment. Thioflavin T
(ThT) fluorescence assay and circular dichroism (CD) experi-
ments indicated that fibril formation is enhanced at low den-
drimer concentrations, while it is prevented at relatively high
dendrimer concentrations. EPR analysis not only has demon-
strated this behavior, but also provided detailed information
on the mechanism of fibril formation and on the diﬀerent be-
havior of the diﬀerently decorated dendrimers. EPR results
also indicate that the perturbations caused by PPI (G5)-
maltose are more eﬀective on PrP (185–208) than on Aβ (1–28),
while PPI (G5)-maltotriose is less eﬀective towards PrP
(185–208) in both promoting aggregation and preventing it
by changing the dendrimer concentration. These results
provide useful information about the mechanism and inter-
actions, which regulate the ability of macromolecules like
dendrimers to promote, prevent or cure neurodegenerative
diseases.140
6. Conclusion
In summary, this review reveals the new face of dendritic poly-
mers as agents to change the size, shape or sheet multiplicity
of other nanomaterials. Indeed, this paper has reviewed
primary covalent–noncovalent interactions between dendritic
polymers and other nanomaterials and also secondary
noncovalent interactions among dendritic polymers, which
can result in modern nanostructures with improved
characteristics.
Because in most cases secondary interactions are driving
forces to change the physicochemical properties of nanomater-
ials, in designing a dendritic polymer to modify nanomaterials
by covalent or noncovalent approaches these types of inter-
actions should be taken into account. This could be achieved
by the modification of the functional groups of dendritic poly-
mers or conjugation of other molecules, such as linear poly-
mers, onto their backbone.
Finally, the consideration of all possible ways of interaction
of dendritic polymers with graphene, CNTs, proteins/peptides
and nanoparticles leds us to gain better knowledge in the
design of novel hybrid nanomaterials.
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